Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2025-12-24 @ 7:47 PM
NCT ID: NCT04742803
Eligibility Criteria: Inclusion Criteria: * Derma Scan showing aging including skin texture, wrinkles, brown spots, and pores. * Patients willing to sign informed consent. * Patients willing to be photographed and video documented * Patients willing to consent to 3 months of treatment Exclusion Criteria: * History of eczema in the treatment area; psoriasis and any other chronic skin conditions * History of actinic (solar) keratosis in the treatment area; * History of hemophilia * History of diabetes * The presence of raised moles, warts on the targeted area. * Collagen vascular diseases or cardiac abnormalities * Blood clotting problems * Active bacterial or fungal infection * Facial melanosis * Malignant tumors * Immunosuppression * Use of blood thinners or prednisone * Corticosteroids within two weeks of the procedure * Chronic liver disease * Porphyria or other skin diseases. * Patient not willing to sign informed consent. * TCA peels in the last 5 weeks * Subject currently has moderate to severe acne on the face. * Microneedling within the last 6 months * Subject has an active infection. * Subject has a history of a bleeding disorder * Subject has a history of keloidal tendency * Subject has received ablative or non-ablative laser treatments in the previous 6 months. * Subject has taken Accutane within the previous 3 months.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 21 Years
Maximum Age: 65 Years
Study: NCT04742803
Study Brief:
Protocol Section: NCT04742803